Therefore, the second aim of our study was to study potential proarrhythmic signals and mechanisms of ivabradine versus metoprolol (that offered the same HR reduction, but did not block hERG) in the rat model of acute non-reperfused MI at various levels. The gene discussed is KCNH2; the disease is myocardial infarction.